Abstract. Humoral and cellular responses were examined among natives and migrants in an area of the Amazon region of Brazil. Rhoptry-associated protein-1 (RAP-1) and RAP-2 expressed in Escherichia coli expression systems, a peptide corresponding to the epitope bound by inhibitory anti-RAP-1 antibodies, and four other RAP-1 and RAP-2 synthetic peptides were used in these studies. Plasma from the native population had greater IgG reactivity to the N-terminal third of RAP-1 than the migrant population; both populations had low levels of IgM to this region of RAP-1. The IgG reactivity to RAP-2 and to the C-terminal third of RAP-1, as well as for all the peptides, including the peptide from the inhibitory domain, were low or absent in both populations. In contrast, there were a high number of subjects with an IgM response to the peptides. Cellular responses were measured by proliferation of peripheral blood mononuclear cells (PBMC) and, in some subjects, by reverse transcription-polymerase chain reaction for interleukin-2 (IL-2), interferon-␥ (IFN-␥), IL-4, and IL-10. Proliferation of PBMC was low when stimulated by recombinant proteins, peptides, or parasite lysate. Both RAP-1 and RAP-2 stimulated cytokine production by donor T cells; IL-2, IL-4, and IFN-␥ RNA transcripts were observed in response to recombinant proteins and parasite lysate, but with no uniform trends. From the observed antibody responses, RAP-1 appears to be more immunogenic than RAP-2.
Malaria is still endemic in more than 90 countries, with more than 120 million clinical cases and more than one million deaths each year (http://www.who.cl/ctd/diseases/mala/ malasit.htm). Immunity to malaria infection is acquired slowly and is rarely, if ever, complete. Although, our understanding of the development of immunity to malaria in humans is limited, a number of potential blood-stage vaccine candidates for Plasmodium falciparum have been identified based upon immunogenicity, sequence conservation, and degree of protection conferred in animal models. 1 Among the vaccine candidates are proteins localized to the rhoptry organelle. Several of these molecules have a high potential for use in polyvalent vaccines against the asexual blood-stage of P. falciparum.
Located near the apical end of the merozoite, the rhoptries appear to be involved in merozoite release, attachment, and invasion of erythrocytes. 2, 3 Monoclonal antibodies have identified a number of rhoptry proteins, including complexes with proteins of 86-37 kD and 140-105 kD. 4, 5 Rhoptryassociated protein 1 (RAP-1) is processed into 86-, 82-, 70-, and 67-kD polypeptides. 4, 6, 7 The RAP-1 products associate noncovalently with either p39 (RAP-2) or p37 (RAP-3). 6, 8, 9 This study focuses on RAP-1 and RAP-2. Promise for their potential role in vaccination comes not only from evidence of conservation, but also from indications of their immunogenicity and protective capacity in both animal trials and in vitro studies. Sequence conservation of the RAP-1 gene is high among both culture-adapted isolates and field samples. [10] [11] [12] Also, monoclonal antibodies (MAbs) against components of these rhoptry protein complexes have successfully inhibited erythrocyte invasion in vitro. [13] [14] [15] [16] Furthermore, Saimiri monkeys immunized with parasite-derived RAP-1/RAP-2/RAP-3 have been protected from a lethal challenge of P. falciparum. 17, 18 Involvement of both antibody-mediated and cell-mediated immune mechanisms have been demonstrated in malaria infection. Elaborate studies in rodent malaria models have delineated crucial roles for T cells and B cells during infection and recovery. [19] [20] [21] In humans, however, the roles of antibodies and other immune effectors responsible for the development of immunity, including the dichotomy of T helper cell subtypes and related cytokines, are not as easily defined. Previously, we demonstrated the production of antibodies to regions of RAP-1 in immune and semi-immune patients in Sudan and Nigeria. In the nearly 30 sera tested, the highest reactivity was observed to a region of RAP-1 containing amino acids 1-294 (RAP-1 ). 11 A T cell epitope, predicted in the octameric repeat region of RAP-1, was confirmed by Jakobsen and others, who also detected serum antibodies to RAP-1 . 22 Recent reports have also demonstrated naturally occurring antibody responses to full length RAP-1 and RAP-2 proteins 23 and the C-terminal one-third of RhopH3, a component of the 140-105-kD complex of P. falciparum rhoptry proteins. 24 In the present study, we characterize human immune responses to RAP-1 and RAP-2, using recombinant proteins and peptides to examine the antibody reactivity and the T cell response (measured by cell proliferation and cytokine induction) in peripheral blood samples obtained from two populations of donors located in the state of Rondonia, Brazil. One donor population consists primarily of migrants who moved to the Amazon Basin from areas not endemic for P. falciparum. The other consists of a population native to the Amazon Basin that reside in a fishing area along the banks of the Rio Madeira, a tributary of the Amazon River.
SUBJECTS, MATERIALS, AND METHODS
Study subjects. Individuals from the Brazilian state of Rondonia were recruited for participation in this study. The Isolation and freezing of PBMC and plasma. The PBMC were purified from 10-30 ml of whole blood by Ficoll-Paque density gradient centrifugation. Cells not immediately used in assays were frozen in RPMI 1640 medium supplemented with 50% AB heat-inactivated normal human serum and 7% dimethylsulfoxide, and transported and maintained in liquid nitrogen, as was plasma. Some assays were performed on site in Porto Velho.
Plasmodium falciparum culture and antigen preparation. The Honduras I/CDC strain (K ϩ ) of P. falciparum (obtained from Dr. Susan Langreth, Uniformed Services University of the Health Sciences, Bethesda, MD) was cultured at 37ЊC in mixed gas using TES-buffered RPMI 1640 medium supplemented with sodium bicarbonate, L-glutamine, gentamicin, and 10% A ϩ human serum and A ϩ or O ϩ human erythrocytes, as previously described. 26 Synchronous cultures were obtained with regular treatments of sorbitol and/ or sedimentation in modified gelatin. 6, 27 Parasite antigen was prepared from cultures with parasitemias (of late stage parasites) Ͼ 60% by lysing parasitized and normal red blood cells (RBC) in 10 mM phosphate buffer, washing in phosphate-buffered saline (PBS) with or without protease inhibitors, sonicating, and pelleting membranes and parasites by centrifugation at 30,000 ϫ g for 20 min at 4ЊC. Samples were frozen in liquid nitrogen until needed.
Synthetic peptides and peptide ELISAs. The T-Sites computer program (Medimmune, Gaithersburg, MD) was used to predict potential T cell epitopes within the RAP-1 and RAP-2. Four peptides, two from RAP-1 (p82A and B) and two from RAP-2 (p39A and B), were chosen for synthesis based upon the results of the T-sites computer program and the feasibility of synthesis. Amino acid numbers and sequences for the peptides are given in Table 1 . Although the T-Sites program identified several possible amino acid sequences within the proteins that were predicted to represent T cell epitopes, many were not feasible for synthesis due to their protein chemistry. None of the peptides were located in regions of repeats. These peptides were synthesized commercially and used without further purification (Genosys, Woodlands, TX).
An epitope bound by several anti-RAP-1 MAbs that inhibit P. falciparum invasion of RBC in vitro was identified by deletion and peptide scanning methods. 15 We call this domain iB-1, short for inhibitory B-cell epitope 1. A peptide corresponding to the iB-1 domain (amino acids 198-211) was synthesized by standard Fmoc chemistry at Molecumetics (Bellevue, WA) and included an additional N-terminal Cys to aid coupling.
Peptide ELISAs were performed in triplicate using 50 l (5 g/ml) of p82A and B and p39A and B peptides or 50 l (1 g/ml) of iB-1 peptide bound to Nunc (Roskilde, Denmark) Maxisorp 96 well plates overnight. The human plasma were used after dilution (1:50) in PBS/0.1% Tween 20/0.1% bovine serum albumin. The secondary antibody was horseradish peroxidase (HRP)-conjugated goat anti-human IgG or goat anti-human IgM (Boehringer Mannheim Biochemicals, Indianapolis, IN). 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS; Zymed, South San Francisco, CA) was used as substrate in the HRP reaction. Reactions were read at 405 nm in an ELISA plate reader. A sample was considered positive when the optical density (OD) value was higher than the average OD of the normal plasma plus three standard deviations.
Expression and purification of recombinant proteins. The RAP-1 1-294 region of RAP-1 was expressed in two forms, one with a carboxyl (C-) terminal 6 His-tag (hexameric histidines) sequence and a second as a dual fusion to both the maltose binding protein (MBP) and 6 His-tag. The production and purification of these 6 His-tagged recombinant proteins are described in more detail elsewhere. 16 Briefly, this region of RAP-1, and all other constructs devised in our laboratory to express RAP-1 and RAP-2, were amplified from genomic DNA of the P. falciparum isolate Honduras I/CDC in a polymerase chain reaction (PCR) and inserted into the Escherichia coli expression vector pQE70 (Qiagen, Valencia, CA). The recombinant protein, A-2-2, was expressed after induction with isopropyl ␤-D-thiogalactoside (IPTG) as a 31-kD recombinant protein. The 6 His sequence permitted purification by Ni ϩ -chelation chromatography according to the manufacturer's recommendations (Qiagen). Purified A-2-2 was used in immunoblot analyses.
To increase the yield of recombinant RAP-1 1-294 , the RAP-1 insert in pA-2-2 was fused to MBP in the bacterial expression vector pMALc (New England Biolabs, Beverly, MA) and a 6 His sequence was inserted at the C-terminus of the RAP-1 coding region. This fusion, termed MBP-RAP-1 , was purified from IPTG-induced bacterial cultures by sequential use of the amylose binding ability of MBP, following the manufacturer's protocols, and the Ni ϩ binding properties of the 6 His-tag domain. The purified MBP-RAP-1 1-294 was essentially homogeneous for a 80-kD band by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The purified protein was dialyzed against PBS, concentrated in SpectroPor dialysis tubing (Spectrum Medical Industries, Los Angeles, CA) using Aquacide (Calbiochem, La Jolla, CA), and redialyzed against PBS. Protein concentration was determined by a Coomassie protein assay (Pierce, Rockford, IL). The cleavage site for Factor Xa was not accessible in any of our MBP fusion proteins. The MBP fusion proteins were used in T cell stimulation experiments.
The MBP-RAP-1 293-707 protein was another MBP fusion protein containing amino acids 293 to 707 of the RAP-1 coding region. This protein was also expressed from pMALc after a 6 His sequence was added to the C-terminus of the RAP-1 coding region by ligation into the expression vector. The MBP-RAP-1 293-707 protein was poorly soluble in the absence of guanidine or urea, which prevented a primary purification step on amylose. The protein was purified on chelated Ni ϩ after solubilization in buffer containing 6 M guanidine-HCl using the batch purification procedure suggested by the manufacturer (Qiagen). Protein was eluted with 250 mM imidazole in buffer containing 8 M urea. Urea was removed by stepwise dialysis against PBS/urea to maintain soluble protein although typically some protein was lost due to precipitation during dialysis.
The recombinant protein 1-1-4, containing RAP-1 514-769 , was the C-terminal most region of RAP-1 expressed. This region was amplified with the sense primer 5Ј-CCCG GGCATGCACGAAGCATCTCAGGATATTGCTGCTG-3Ј and the antisense primer, 5Ј-GCTCTAGATTCTTAATCTA-ATCTCTTGAAGGCA-3Ј. The PCR product was cloned into pQE70 and expressed after induction with IPTG. Expression and purification of protein 1-1-4 followed the methodology used to isolate A-2-2. Protein 1-1-4 was used for immunoblot analyses.
The mature RAP-2 protein, containing amino acids 22-398, was expressed from pQE60 (Qiagen) after induction with IPTG. The RAP-2 gene was amplified with the primers sense 5Ј CCATGGATAAGTGTGAAACTGAATTTTCC 3Ј and anti-sense 5Ј GGATCCAAGAACATTTAATTCT CTA-ATAGC 3Ј. Purification of recombinant RAP-2 (rp39) followed the procedures described above for MBP-RAP-1 293-707 except for the following differences. After induction, the cell pellet was resuspended in sonication buffer (50 mM sodium phosphate, pH 7.8, 300 mM NaCl). After freeze/thawing, the mixture was sonicated and centrifuged at 300-350 ϫ g for 10 min. The clarified extract was batch purified on Ni ϩ agarose using 250 mM imidazole for elution. Much of the rp39 precipitated during stepwise dialysis into PBS. Protein in the precipitate was quantitated and used in experiments.
Recombinant RAP-1 and RAP-2 were also kindly provided by Dr. Allen Saul (Queensland Institute of Medical Research, Brisbane, Australia). This recombinant RAP-1 molecule (here called rRAP-1) contains amino acids 23-608 and was expressed as a 6 His C-terminal protein. The recombinant RAP-2 (rRAP-2) consists of the entire mature protein (amino acids 22-398) 9 and was expressed as a 6 His N-terminal protein. Both proteins were purified over a Ni ϩ chelating resin as an initial purification, followed by further purification by isotachophoresis. 28 Western blot analysis. Purified recombinant proteins (50-150 ng per linear centimeter of gel) were resolved by SDS-PAGE (8% polyacrylamide gel) and transferred to nitrocellulose membrane (Schleicher and Schuell, Keene, NH). Human plasma was diluted 1:10 in 50 mM Tris/0.01% sodium azide/150 mM NaCl with 1% casein and used as primary antibody. Goat anti-human IgG-HRP and goat antihuman IgM-HRP conjugated antibodies were used as secondary antibodies. The reactions were developed with aminoethyl carbazole (Zymed). Scoring of Western blots was visual and relative to other samples.
Proliferation of PBMC. Frozen PBMC were thawed at 37ЊC and washed three times in incomplete RPMI 1640 medium. Fresh or thawed PBMC were plated in triplicate in 96-well, U-bottom plates (Corning, Corning, New York) in complete RPMI 1640 (10% human AB serum, 50 M 2-mercaptoethanol, 50 g/ml of gentamicin, and 2 mM L-glutamine) in the presence of parasite lysate, recombinant protein, or synthetic peptide. Recombinant proteins with MBP (MBP-RAP-1 and MBP-RAP-1 293-707 ) were used at a concentration of 23 g/ml to provide 10 g/ml of the parasite protein with 1.5 ϫ 10 5 cells/well. Purified MBP and recombinant proteins expressed with only the 6 His tag were used at a concentration of 10 g/ml. Lysates of infected or uninfected RBC were used to give 10 6 or 10 7 cell equivalents, as indicated. Peptides were used at a concentration of 20 g/ ml, with 2 ϫ 10 4 cells/well. Parasite lysate was used at a concentration of 20 g/ml in the peptide experiments instead of using cell equivalents. Cells stimulated with 1% phytohemaglutinin (PHA) served as positive controls, and medium alone served as a negative control. Cells were incubated at 37ЊC in CO 2 for six days and pulsed during the last 16 hr of culture with 1 Ci/well of 3 H-thymidine (ICN, Costa Mesa, CA), harvested, and incorporated radioactivity was determined. Results are expressed as the stimulation index (SI): the mean cpm in experimental cultures/mean cpm in the medium controls. An SI Ն 4 was considered positive. Isolation of RNA and reverse transcription PCR (RT-PCR) for cytokine analysis. The PBMC were cultured for 72 hr with antigen as described above for our proliferation studies, except that two wells were used per antigen treatment, instead of three, resulting in a total of 3 ϫ 10 5 cells per antigen treatment. Isolation of total RNA from cell pellets followed a modified method of Chomczynski and Sacchi. 29 Synthesis of cDNA followed the manufacturer's recommendations for Superscript Reverse Transcriptase using oligo(dT) as a primer (Life Technologies, Gaithersburg, MD).
The cDNA was normalized with respect to the constitutively expressed ␤-actin gene prior to the cytokine PCR. Serial dilutions of cDNA were used to verify that the ␤-actin PCR conditions were within the linear range. Normalized cDNA were amplified by PCR using Taq polymerase with 0.2 M of the respective 5' and 3' external primers in a 50-l reaction. Interleukin-2 (IL-2), IL-4, and IL-10 amplification reactions were as follows: denaturation at 94ЊC for 30 sec, annealing at 55ЊC for 30 sec, and elongation at 72ЊC for 90 sec; 30 cycles for ␤-actin, IL-2, and IL-4 and 25 cycles for IL-10. Interferon-␥ (IFN-␥) was amplified for 30 cycles: 30 sec at 94ЊC, 45 sec at 60ЊC, and 1.5 min at 72ЊC. The nucleotide sequences for the sense and anti-sense oligonucleotide PCR primers for IL-2, IL-4, IL-10, and IFN-␥ have been published elsewhere. 30, 31 For comparative analysis of the cytokine transcripts, PCRs were probed by Southern blot hybridization. Blots were hybridized with DNA sequences for human ␤-actin, IL-2, IL-4, IFN-␥, and IL-10 labeled with 32 ␣-P-ATP in a primer extension reaction with a random nonamer (Stratagene, La Jolla, CA). 32 Where indicated, Southern blots were scanned for quantitation on a Storm Phosphorimager (Molecular Dynamics, Sunnyvale, CA).
Statistical analysis. Analysis of variance was performed to determine the significance of differences in time of residence between populations. The significance of differences between populations in the prevalence of positive responses to peptides was determined by 2 analysis.
RESULTS
Study populations. Samples were taken from study groups in 1993 and 1995. Characteristics of the 1995 Rondonian study populations are shown in Table 2 because these samples were used in most assays unless noted. There was no significant difference in the mean ages among the populations, but differences in mean time of residence were significantly different (P Ͻ 0.01). All residents of Ribeirinha were natives of the area; thus, age distribution was identical to the residence time.
Binding of antibodies to recombinant RAP-1 and RAP-2. Anti-RAP-1-and anti-RAP-2-specific IgG and IgM in 10 Colina samples and nine Ribeirinha samples were assayed on Western blots (Table 3) . His-tagged recombinant proteins A-2-2 (containing RAP-1 1-294 ), 1-1-4 (containing RAP-1 514-769 ), and rp39 (RAP-2) were used for these analyses. All of the Ribeirinha samples and nine of the 10 Colina samples had IgG recognizing RAP-1 . Three samples from Colina and two from Ribeirinha were tested for reactivity to RAP-1 . None of these were positive. Because of previous observations that African sera have low anti-RAP-1 606-769 antibody titers, 11 the screening was not extended to the remaining Brazilian samples. The IgG antibody reactivity to RAP-2 was tested in nine samples from Colina and seven from Ribeirinha. Only two Colina samples and one Ribeirinha sample were positive ( Table 3 ), indicating that antibodies to denatured recombinant RAP-2 are less common in these Brazilian subjects than antibodies to denatured recombinant RAP-1. Because we observed low signal intensity of IgM to the RAP-1 1-294 region (Table 3 ) and only small volumes of plasma were available, the binding of patient IgM 
* Positive responses were based on a ratio greater than 1 obtained by dividing the mean patient optical density by the mean of negative controls plus 3 SD. a.a. ϭ amino acids; NP ϭ number of positive individuals.
† The number of individuals responding with IgM to peptide 82B were significantly different among the two populations (P Ͻ 0.02), and the difference between the number of individuals responding with IgG to peptide 39A was marginally significant (P Ͻ 0.06).
to recombinant RAP-2 (using rp39) and RAP-1 514-769 (using 1-1-4) was not investigated.
Antibody responses of Brazilians and Africans to the inhibitory epitope iB-1. Several anti-RAP-1 mAbs that inhibit invasion in vitro bind an epitope (iB-1) at residues 200-211 in RAP-1. 15 To determine whether there were significant differences in anti-iB-1 antibody levels in the Colina and Ribeirnha populations, plasma were tested on peptide iB-1 (Table 1) by ELISA. No significant differences were observed between these two populations: 10 Colina plasma samples had a mean OD of 0.1169 (SEM ϭ 0.0050) and nine Ribeirinha samples had a mean OD of 0.1143 (SEM ϭ 0.0073). In addition, neither population differed significantly from three North American negative control sera (mean OD ϭ 0.1050, SEM ϭ 0.0098). Two of the ten Colina samples (a 50-year-old and a 17-year-old, both residents in Rondonia for nine years) and two Ribeirinha samples (a 25-year-old and a 44-year-old) had OD levels that were greater than 2 SD above the mean of the negative controls, but less than the 3 SD cut-off level used here to establish significance. As with the Brazilian samples, there were no significant antiiB-1 antibody titers in five Nigerian immune sera (mean OD ϭ 0.1112, SEM ϭ 0.0050) or one Sudanese serum sample (single value of 0.087) compared with the negative controls. These results do not show a correlation between anti-iB-1 antibody titers and exposure to P. falciparum infection or anti-malarial immunity.
Reactivity of Rondonian antibodies to RAP-1 and RAP-2 synthetic peptides. To examine the antibody responses to other epitopes in RAP-1 and RAP-2, ELISAs were performed with 20 Ribeirinha plasma samples and 16 Colina samples using four synthetic peptides. Two of these peptides contained sequence from RAP-1 and two from RAP-2 sequence (Table 1) . On average, fewer than 20% of the individuals had IgG antibodies that bound any of the four peptides (Table 4) . However, for each of the four peptides used, the percentage of the native (Ribeirinha) population with antibodies to these peptides was higher than that of the migrant population. The percentage of samples with IgM that bound the peptides was greater than that seen for IgG. As with IgG, the percentage of individuals with an IgM response was higher in the native population (Table 4) Of these, one from Ribeirinha had an SI of 11.3 following incubation with 10 6 infected RBC equivalents, and two from Colina had an SI Ͼ 4 (SI of 4 and 6) following incubation with 10 7 infected RBC equivalents. The PBMC from two US residents who had contracted falciparum malaria while traveling abroad were also tested; their cells failed to proliferate to parasite lysate.
Proliferative responses of Colina and Ribeirinha PBMC were also examined using the peptides p39A, p39B, and p82B, which were predicted to contain T cell epitopes. Twenty samples from the native population (Ribeirinha) and 17 from the migrant population (Colina) were tested with individual peptides, PHA, or P. falciparum blood-stage antigens. All samples proliferated with PHA. Only two samples had an SI Ͼ four (considered positive) when exposed to any of the peptides. Both positive samples were PBMC collected from subjects in the migrant population. Colina sample 30 (CL30) proliferated with peptide p39A (SI ϭ 4.3) and sample CL15 proliferated with p82B (SI ϭ 9.2). Parasite lysate produced an SI Ͼ 4 in a total of 13 patients (5 migrant [29%], and 8 native [40%]). Sample CL30 had an SI of 3.5, while sample CL15 had an SI of 85.
Cytokine responses of patient PBMC to recombinant RAP-1 and RAP-2. In addition to examining proliferation FIGURE 1. Cytokine expression by peripheral blood mononuclear cells (PBMC) from patient Ron-16 stimulated by recombinant rhoptryassociated protein-1 (RAP-1) and RAP-2 antigens. The antigen rp39 was purified by Ni ϩ -resin chromatography, and proteins rRAP-1 and rRAP-2 were purified by sequential chromatography on Ni ϩ -resin and isotachophoresis. The PBMC culture, reverse transcription-polymerase chain reaction, and quantitation were performed as described in the Subjects, Materials, and Methods. Stimulation indices are provided (ratio). IL-2 ϭ interleukin-2; IFN-gamma ϭ interferon-gamma; PHA ϭ phytohemagglutinin.
of PBMC, we were interested in the cytokines produced following stimulation with the recombinant rhoptry proteins. These analyses could identify T helper cell subtypes that are stimulated by these antigens, as well as further characterize T cell activation, since it may occur separate from T cell proliferation. The T h 1-related cytokines IL-2 and IFN-␥ and the T h 2-related cytokines IL-4 and IL-10 were measured by RT-PCR following incubation of PBMC with recombinant proteins and parasite lysate. The RT-PCR was necessary since the low number of PBMC obtained from patients prevented direct analysis of all four cytokines in culture supernatants. Maltose binding protein was used as a control for MBP fusion proteins and uninfected RBC lysate was a control for parasite lysate.
The PBMC from eight patients sampled in 1993 were incubated with the MBP fusion proteins MBP-RAP-1 1-294 and/ or MBP-RAP-1 293-707 . The MBP-RAP-1 293-707 protein stimulated IL-2 and IL-4 gene expression in one patient (MBP-RAP-1 was not tested with these cells). This patient was a native of Ribeirinha with a P. falciparum parasitemia at the time of blood collection. Since purified MBP alone stimulated synthesis of the same cytokine RNA transcripts in the other samples, cytokine stimulation in response to the recombinant RAP-1 proteins could not be confirmed in those samples. Qualitative analysis indicated that IFN-␥ and IL-10 were more frequently expressed in response to purified MBP than IL-2 and IL-4. Parasite lysate stimulated IL-2, IL-4 and IFN-␥ in three of these patients; in other patients, uninfected RBC lysate also stimulated expression of cytokines.
To circumvent background problems caused by the use of MBP, antigens were used without the MBP fusion partner. These recombinant proteins, rRAP-1 (containing RAP-1 ) and two different preparations of RAP-2 (termed rp39 and rRAP-2), corresponding to the mature parasite RAP-2, were used to stimulate PBMC from three donors, and the resulting cytokine RNA transcripts were quantified. Two different preparations of recombinant RAP-2 were used to compare the effects two different purification methods might have on cell stimulation. The rRAP-1 protein stimulated IL-4 eight-fold and IL-2 two-fold over medium alone in PBMC from a donor who mined the river for gold (Figure 1 ). Neither rp39 nor rRAP-2 stimulated cytokine message in this sample. This patient, a 10-year resident of the region, had a P. falciparum parasitemia at the time of blood collection. Using PBMC from a Colina donor, rRAP-1 also stimulated IL-2 three-fold over medium alone. The rRAP-2 protein stimulated a four-fold increase of IFN-␥ and a five-fold increase of IL-2 over media in this same patient; the low cell numbers recovered from this patient were not sufficient to test both preparations of recombinant RAP-2. The PBMC from the third donor, a Colina resident, did not produce any of the three cytokines in response to rRAP-1 (over medium background) even though PHA stimulated IL-2 and IL-4 (but not IFN-␥) in this donor's cells. There were not sufficient cells to test either RAP-2 preparation. The IL-10 message was not examined in these patients. These results indicate that recombinant forms of RAP-1 and RAP-2 stimulate production of IL-2, IL-4, and IFN-␥ in PBMC isolated from Brazilian subjects. Lysates from parasitized RBC also stimulated expression of these same three cytokines.
DISCUSSION
In the present study, we examined both antibody and T cell responses to RAP-1 and RAP-2 in humans. Populations of malaria patients in Brazil provided us with the opportunity to measure cellular and humoral responses in populations differing in residence time in an area endemic for P. falciparum and thus potentially differing in levels of immunity. To accomplish this, we produced recombinant proteins and synthesized peptides of both RAP-1 and RAP-2.
The antibody responses of these Brazilian subjects to RAP-1 1-294 (using A-2-2 as antigen) were prevalent, as reported previously for Nigerian, Sudanese, and Ghanaian sera. 11, 22 Within the Brazilian samples, there were marked differences in the IgG responses to recombinant RAP-1 and RAP-2 between the native and migrant populations ( Table  3) . The native population demonstrated much higher reactivity to RAP-1 than the migrant population. These results might lead one to predict that a sample population consisting of more recent immigrants would have even lower levels of anti-RAP-1 antibody. However, such a prediction contrasts with the recent observation that, after two nonexposed volunteers were infected twice with P. falciparum, anti-RAP-1 antibodies increased substantially to levels found in immune individuals. 23 These observations may mean that antibody responses to only particular epitopes in RAP-1 or other parasite antigens are predictive of a protective immune response. The IgM responses to RAP-1 were not prevalent in either population, and we did not pursue examination of IgM responses to the other regions of RAP-1 or recombinant RAP-2. It was previously shown that African sera have low antibody binding to RAP-1 606-769 . 11 To determine whether this low reactivity was restricted to African samples, we screened several Brazilian samples against RAP-1 514-769 (using 1-1-4 recombinant antigen). None of the five plasma samples examined contained IgG specific for the 1-1-4 recombinant protein, and this analysis was not extended to additional samples.
In the present study, the IgG response to recombinant RAP-2 was weak and evident in only three (16%) of 19 subjects, two natives and one migrant. While this manuscript was in review, Stowers and others published results on naturally occurring antibody responses to RAP-1 and RAP-2 in Papua New Guineans. 23 These investigators included both recombinant and parasite-derived forms of the proteins in their study. They found by immunoblot that 86% and 82% of individuals more than 30 years of age had antibodies that recognized parasite-derived RAP-1 and RAP-2, respectively. The percentage of responders decreased slightly when tested with recombinant RAP-2 to 68%, a higher percentage than our 16%. Similar to our observations found here, they also reported that rRAP-2 was less well recognized compared with rRAP-1.
The humoral immune response to both RAP-2 and RAP-1 has also been examined in rabbits and outbred mice. Stowers and others 33 reported that antisera from mice immunized with rRAP-2 had antibody titers 1,000-fold less than those produced with rRAP-1. In addition, they reported a long persistence of RAP-1-specific antibody in rabbits after only a single booster immunization. Our results with the Brazilian plasma showing greater antibody reactivity with RAP-1 than RAP-2 agree strongly with animal and Papua New Guinean results of Stowers and others. 23, 33 Because only one of 10 mice immunized with rRAP-2 recognized the protein by immunoblot, it was concluded that recognition of native RAP-2 may be more conformationally dependent than RAP-1. 33 However, when sera from rabbits immunized with either nonreduced parasite-derived RAP-1 or a mixture of nonreduced parasite-derived RAP-2/RAP-3 6 were compared by immunoprecipitation of radiolabeled parasite antigens, anti-RAP-1 serum had higher avidity or antibody titer (Howard RF, unpublished data) . This may mean that conformation of the immunizing antigen is not solely responsible for differences in immunogenicity. Nevertheless, it is possible that since RAP-2 and RAP-1 are normally found in complexes in the parasite, 4, 6 antibody binding to RAP-2 may be artificially lowered when the polypeptides are assayed using uncomplexed or denatured molecules.
Harnyuttanakorn and others 15 mapped epitopes of several inhibitory anti-RAP-1 MAbs and found that five MAbs from four different mice recognized the same linear peptide sequence (iB-1). The fact that four different mice produced antibodies to the same amino acid sequence suggested peptide iB-1 represents an immunodominant epitope of RAP-1. We tested this possibility in ELISAs using plasma from Brazilians, Sudanese, and Nigerians naturally exposed to P. falciparum. None of the Sudanese or Nigerian sera, even though previously shown to bind epitopes in the RAP-1 1-294 region, 11 recognized the iB-1 peptide in the ELISA. These results suggest that neither the natives of Rondonia, who might be expected to have a greater level of immunity to P. falciparum infection, nor the more recent migrants to Rondonia, nor immune Africans have greater levels of circulating anti-iB-1 antibodies than do healthy, unexposed North American controls and argue that iB-1 is not an immunodominant epitope in humans. Our recent observations of sera from P. falciparum-infected owl monkeys support this conclusion. 16 Jakobsen and others 22 compared PBMC from Ghanaian children and adults for their abilities to recognize RAP-1 by measuring T cell proliferation and plasma IgG and IgM reactivities. They found that PBMC of Ghanaian children had higher proliferative responses to a RAP-1 recombinant protein (containing amino acids 24 to 294) and a synthetic peptide corresponding to an antigenic region containing two serine-rich repeats than did adults. The IgG reactivity to the peptide was less common (including none of the children's sera) than to the recombinant protein and, although IgM responses were less common than IgG responses to the recombinant protein for both adults and children, a few from each group had IgM antibodies to the peptide. Our observations of more prevalent IgG responses to recombinant proteins and greater IgM responses to peptides are similar to the results of Jakobsen and others. 22 Proliferation of T cells provides one, but not the only measure of T cell responsiveness. This is illustrated by the Ͼ 60% of patients whose cells did not proliferate to whole parasite lysate, even though the verbal information taken from the patients indicated they had experienced up to 200 prior infections. In addition, there was no proliferation of PBMC to recombinant proteins. In many studies, an SI of 2.5 is considered positive compared with our value of 4.0.
Even if this lower index was chosen as a determinant in our studies, the percentage of individuals with a positive peptide T cell response would still remain Ͻ 10%. The finding of generally low and infrequent proliferative response of T cells in the peripheral blood has also been found with other antigens, e.g., ring-infected erythrocyte surface antigens. 34 Potential reasons for low responsiveness in general include sequestration of malaria-specific T cells outside of the peripheral blood, the presence of CD8 suppressor cells, inadequate IL-2 production, and the effects of fever and transmission season. [35] [36] [37] Another possible explanation for the low stimulation by peptides is that computer algorithms are perhaps not the best predictor for identifying T cell epitopes for these antigens.
To the best of our knowledge, this is the first report that RAP-1 and RAP-2 proteins stimulate cytokine gene expression in human PBMC. These analyses provided an additional measure of T cell stimulation by these antigens besides proliferation. We were able to demonstrate cytokine gene activation following incubation with parasite lysate, MBP-RAP-1 514-769 , rRAP-1 and rRAP-2, even though the sample size was small. Given the sample size, we were unable to compare responses between the native and migrant populations or to determine trends by the different recombinant proteins. We did, however, observe IL-4 production in vitro by cells of two patients with active P. falciparum infections at the time of blood collection. The PBMC of one of these individuals produced IL-4 in response to rRAP-1. The PBMC of the other produced IL-4 in response to parasite lysate and MBP-RAP-1 514-769 . In addition, rRAP-2 induced both IFN-␥ and IL-2, but not IL-4, in an 11-year-old resident of Colina. Expression of the IL-2, IL-4, and IFN-␥ genes was not stimulated by rRAP-1 in cells from a seven-year Colina resident whose last documented malaria infection was two months earlier. The detection of trends in cytokine induction will definitely require larger sample sizes. Although drawing conclusions in humans is difficult due to the high degree of variability in age, exposure, and genetic background, it is the differences between these groups, as identified in this study and others, that merit further attention. Such studies will undoubtedly use both controlled vaccination trials with RAP-1 and RAP-2.
